Cardiovascular disease (CVD) has been the major cause of death worldwide for many years. Comorbidities include obesity, altered lipid profiles, and insulin resistance are frequently linked to CVD. For obesity, it is one of the largest and fastest growing public health problems in the world. The pharmacological options for obesity treatment remain quite limited. Recently, one of the potential exciting research areas is the development of innovative therapeutic molecular vaccines and immunoglobulins.
(2023). Obesity and Cardiovascular disease: A Promising Approach. Cardiovascular Research Prove Journal, 7(1), -. doi: 10.21608/cvrepj.2023.351112
MLA
. "Obesity and Cardiovascular disease: A Promising Approach". Cardiovascular Research Prove Journal, 7, 1, 2023, -. doi: 10.21608/cvrepj.2023.351112
HARVARD
(2023). 'Obesity and Cardiovascular disease: A Promising Approach', Cardiovascular Research Prove Journal, 7(1), pp. -. doi: 10.21608/cvrepj.2023.351112
VANCOUVER
Obesity and Cardiovascular disease: A Promising Approach. Cardiovascular Research Prove Journal, 2023; 7(1): -. doi: 10.21608/cvrepj.2023.351112